INCY 5 (Jakafi 5 mg)

Generic Name: ruxolitinib

Pill imprint INCY 5 has been identified as Jakafi 5 mg.

Jakafi is used in the treatment of myelofibrosis; myeloproliferative disorders and belongs to the drug class multikinase inhibitors. Risk cannot be ruled out during pregnancy. Jakafi 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for INCY 5

Jakafi 5 mg INCY 5
Jakafi
Generic Name:
ruxolitinib
Imprint:
INCY
5
Strength:
5 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Incyte Corporation
National Drug Code (NDC):
50881-0005
Inactive Ingredients:
microcrystalline cellulose
lactose monohydrate
silicon dioxide
hydroxypropyl cellulose
povidone
sodium starch glycolate type A potato
magnesium stearate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)